SCHEMBL21169786

SCHEMBL21169786

BC(B)(O)C(B)(Sc1ccccc1Nc1nc(Cl)ncc1Cl)C(B)(O)O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ULK1 O75385 1/20 0.35
MAPK8 P45983 2/20 0.35
CDK2 P24941 4/20 0.35
CCNA2 P20248 3/20 0.35
CDK9 P50750 3/20 0.35
CCNK O75909 2/20 0.35
CCND3 P30281 2/20 0.35
CDK6 Q00534 2/20 0.35
MAPK10 P53779 5/20 0.35
MAPK9 P45984 4/20 0.35
AURKA O14965 1/20 0.35
BCL6 P41182 2/20 0.34
ALK Q9UM73 1/20 0.34
LRRK2 Q5S007 2/20 0.33
KMT2A Q03164 1/20 0.32
IGF1R P08069 1/20 0.32
CDC7 O00311 1/20 0.32
DAPK3 O43293 1/20 0.32
JAK2 O60674 1/20 0.32
ROCK2 O75116 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19557698 0.88 CCNA2 (0.38) ULK1MAPK8CDK2CCNA2CDK9
SCHEMBL19557729 0.83 MAPK8 (0.42) ULK1MAPK8CDK2CCNA2CDK9
SCHEMBL24073506 0.78 CCNA2 (0.44) ULK1MAPK8CDK2CCNA2CDK9
SCHEMBL30223473 0.78 CCNA2 (0.44) ULK1MAPK8CDK2CCNA2CDK9
SCHEMBL25839416 0.75 LRRK2 (0.43) ULK1MAPK8CDK2CCNA2CDK9
SCHEMBL16204249 0.74 CDK9 (0.41) ULK1CDK2CCNA2CDK9CCNK
SCHEMBL24716303 0.74 KMT2A (0.44) ULK1MAPK8CDK2CCNA2CDK9
SCHEMBL2062564 0.73 IGF1R (0.54) ULK1CDK2CCNA2CDK9CCNK
SCHEMBL30833698 0.72 ULK1 (0.43) ULK1MAPK8CDK2CCNA2CDK9
SCHEMBL17879578 0.72 CDK9 (0.39) ULK1CDK2CCNA2CDK9CCNK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2990405-B1 DEUTERATED DIAMINOPYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SUCH COMPOUNDS SUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD (CN) 2019-07-17 EP disclosed